Do analysts prefer SRTS or TMDIF?

Sensus Healthcare presently has a consensus price target of $5.83, indicating a potential upside of 101.85%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Sensus Healthcare is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer TMDIF or POCI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer CVRX or TMDIF?

CVRx presently has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Given CVRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe CVRx is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, CVRX or TMDIF?

Titan Medical has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 0.64 -$53.31M -$1.98 N/A Titan Medical $17.63M 0.54 $6.95M $0.05 1.66

Is CVRX or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Titan Medical's return on equity of -82.31% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Titan Medical N/A -82.31% -51.47%

Do analysts prefer TMDIF or SNWV?

Sanuwave Health has a consensus price target of $47.00, suggesting a potential upside of 737.79%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Sanuwave Health 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Do analysts prefer TMDIF or IINN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, TMDIF or IINN?

Titan Medical has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Titan Medical $17.63M 0.54 $6.95M $0.05 1.66 Inspira Technologies OXY B.H.N. $289K 196.54 -$13.22M N/A N/A

Is TMDIF or IINN more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Titan Medical's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Inspira Technologies OXY B.H.N. N/A N/A N/A

Titan Medical (TMDIF) Competitors

$0.11 +0.02 (+26.87%)

As of 10/13/2026

Compare

TMDIF vs. SRTS, POCI, CVRX, SNWV, and IINN

Should you buy Titan Medical stock or one of its competitors? Titan Medical's main competitors and comparable companies include Sensus Healthcare (SRTS), Precision Optics (POCI), CVRx (CVRX), Sanuwave Health (SNWV), and Inspira Technologies OXY B.H.N. (IINN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Titan Medical compare to Sensus Healthcare?

Sensus Healthcare (NASDAQ:SRTS) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Titan Medical has lower revenue, but higher earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A
Titan Medical	$17.63M	0.54	$6.95M	$0.05	1.66

Titan Medical has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Titan Medical	N/A	-82.31%	-51.47%

Sensus Healthcare has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

In the previous week, Sensus Healthcare had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Sensus Healthcare and 0 mentions for Titan Medical. Sensus Healthcare's average media sentiment score of 1.82 beat Titan Medical's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Very Positive
Titan Medical	Neutral

Sensus Healthcare presently has a consensus price target of $5.83, indicating a potential upside of 101.85%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Sensus Healthcare is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by company insiders. Comparatively, 0.0% of Titan Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Sensus Healthcare beats Titan Medical on 11 of the 15 factors compared between the two stocks.

How does Titan Medical compare to Precision Optics?

Titan Medical (NASDAQ:TMDIF) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Titan Medical has a net margin of 0.00% compared to Precision Optics' net margin of -11.51%. Precision Optics' return on equity of -23.92% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Precision Optics	-11.51%	-23.92%	-13.05%

In the previous week, Precision Optics had 5 more articles in the media than Titan Medical. MarketBeat recorded 5 mentions for Precision Optics and 0 mentions for Titan Medical. Precision Optics' average media sentiment score of 0.40 beat Titan Medical's score of 0.00 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Precision Optics	Neutral

Titan Medical has higher earnings, but lower revenue than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.54	$6.95M	$0.05	1.66
Precision Optics	$31.53M	1.59	-$3.63M	-$0.46	N/A

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Titan Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.34, meaning that its stock price is 66% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Precision Optics beats Titan Medical on 9 of the 14 factors compared between the two stocks.

How does Titan Medical compare to CVRx?

CVRx (NASDAQ:CVRX) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

CVRx has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 16.6% of CVRx shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Titan Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Titan Medical's return on equity of -82.31% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Titan Medical	N/A	-82.31%	-51.47%

CVRx presently has a consensus price target of $4.30, suggesting a potential upside of 216.18%. Given CVRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe CVRx is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, CVRx had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for CVRx and 0 mentions for Titan Medical. CVRx's average media sentiment score of 0.65 beat Titan Medical's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Overall Sentiment
CVRx	Positive
Titan Medical	Neutral

Titan Medical has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	0.64	-$53.31M	-$1.98	N/A
Titan Medical	$17.63M	0.54	$6.95M	$0.05	1.66

Summary

CVRx beats Titan Medical on 10 of the 16 factors compared between the two stocks.

How does Titan Medical compare to Sanuwave Health?

Titan Medical (NASDAQ:TMDIF) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Sanuwave Health has higher revenue and earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.54	$6.95M	$0.05	1.66
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market.

Sanuwave Health has a net margin of 32.38% compared to Titan Medical's net margin of 0.00%. Sanuwave Health's return on equity of 1,728.10% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Sanuwave Health	32.38%	1,728.10%	39.04%

In the previous week, Sanuwave Health had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for Sanuwave Health and 0 mentions for Titan Medical. Sanuwave Health's average media sentiment score of 0.60 beat Titan Medical's score of 0.00 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Sanuwave Health	Positive

Sanuwave Health has a consensus price target of $47.00, suggesting a potential upside of 737.79%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Sanuwave Health beats Titan Medical on 16 of the 16 factors compared between the two stocks.

How does Titan Medical compare to Inspira Technologies OXY B.H.N.?

Titan Medical (NASDAQ:TMDIF) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Inspira Technologies OXY B.H.N.	Neutral

Titan Medical has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.54	$6.95M	$0.05	1.66
Inspira Technologies OXY B.H.N.	$289K	196.54	-$13.22M	N/A	N/A

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its share price is 116% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. beats Titan Medical on 7 of the 9 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMDIF vs. The Competition

Export

Metric	Titan Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.01M	$5.52B	$7.25B	$13.04B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	-0.08	25.48	275.44	25.51
Price / Sales	0.68	66.54	562.05	79.58
Price / Cash	0.02	32.25	77.16	53.04
Price / Book	0.10	5.81	10.64	6.00
Net Income	$6.95M	$146.14M	$3.49B	$380.50M
7 Day Performance	N/A	-1.66%	-3.21%	-3.35%
1 Month Performance	-12.47%	-4.35%	-7.65%	-6.23%
1 Year Performance	-78.06%	0.80%	2.92%	-3.96%

Titan Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMDIF Titan Medical	N/A	$0.11 +26.9%	N/A	-80.8%	$12.01M	$17.63M	N/A	50	Gap Up
SRTS Sensus Healthcare	3.4853 of 5 stars	$2.97 -0.3%	$5.83 +96.4%	-10.0%	$48.89M	$27.48M	N/A	60	Positive News
POCI Precision Optics	0.2884 of 5 stars	$4.40 -1.5%	N/A	+7.5%	$48.21M	$31.53M	N/A	90
CVRX CVRx	3.9836 of 5 stars	$1.56 +0.3%	$4.30 +176.5%	-85.0%	$41.43M	$56.65M	N/A	223	Gap Down
SNWV Sanuwave Health	2.4106 of 5 stars	$4.72 -2.0%	$47.00 +895.3%	-83.2%	$40.61M	$44.05M	19.68	55	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMDIF) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Titan Medical (TMDIF) Competitors

TMDIF vs. SRTS, POCI, CVRX, SNWV, and IINN

How does Titan Medical compare to Sensus Healthcare?

Summary

How does Titan Medical compare to Precision Optics?

Summary

How does Titan Medical compare to CVRx?

Summary

How does Titan Medical compare to Sanuwave Health?

Summary

How does Titan Medical compare to Inspira Technologies OXY B.H.N.?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Titan Medical (TMDIF) Competitors

TMDIF vs. SRTS, POCI, CVRX, SNWV, and IINN

How does Titan Medical compare to Sensus Healthcare?

Which has better valuation and earnings, SRTS or TMDIF?

Is SRTS or TMDIF more profitable?

Which has more risk and volatility, SRTS or TMDIF?

Does the media refer more to SRTS or TMDIF?

Do analysts prefer SRTS or TMDIF?

Do insiders & institutionals believe in SRTS or TMDIF?

Summary

How does Titan Medical compare to Precision Optics?

Is TMDIF or POCI more profitable?

Does the media favor TMDIF or POCI?

Which has preferable valuation & earnings, TMDIF or POCI?

Do insiders and institutionals believe in TMDIF or POCI?

Which has more volatility and risk, TMDIF or POCI?

Do analysts prefer TMDIF or POCI?

Summary

How does Titan Medical compare to CVRx?

Which has more risk & volatility, CVRX or TMDIF?

Do institutionals & insiders have more ownership in CVRX or TMDIF?

Is CVRX or TMDIF more profitable?

Do analysts prefer CVRX or TMDIF?

Does the media prefer CVRX or TMDIF?

Which has higher valuation and earnings, CVRX or TMDIF?

Summary

How does Titan Medical compare to Sanuwave Health?

Which has better valuation & earnings, TMDIF or SNWV?

Do insiders & institutionals hold more shares of TMDIF or SNWV?

Which has more volatility & risk, TMDIF or SNWV?

Is TMDIF or SNWV more profitable?

Does the media favor TMDIF or SNWV?

Do analysts prefer TMDIF or SNWV?

Summary

How does Titan Medical compare to Inspira Technologies OXY B.H.N.?

Do analysts prefer TMDIF or IINN?

Is TMDIF or IINN more profitable?

Does the media prefer TMDIF or IINN?

Which has stronger earnings and valuation, TMDIF or IINN?

Do institutionals and insiders believe in TMDIF or IINN?

Which has more risk and volatility, TMDIF or IINN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools